Leif Håkansson

1.4k total citations
42 papers, 1.1k citations indexed

About

Leif Håkansson is a scholar working on Oncology, Immunology and Surgery. According to data from OpenAlex, Leif Håkansson has authored 42 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 21 papers in Immunology and 6 papers in Surgery. Recurrent topics in Leif Håkansson's work include Immunotherapy and Immune Responses (14 papers), Cancer Immunotherapy and Biomarkers (13 papers) and Immune Cell Function and Interaction (5 papers). Leif Håkansson is often cited by papers focused on Immunotherapy and Immune Responses (14 papers), Cancer Immunotherapy and Biomarkers (13 papers) and Immune Cell Function and Interaction (5 papers). Leif Håkansson collaborates with scholars based in Sweden, Netherlands and United Kingdom. Leif Håkansson's co-authors include Bertil Gustafsson, Annika Håkansson, Lennart Krysander, Rune Sjödahl, Gunnar Adell, B Boeryd, B Frånlund, Birgitta Sander, Jan Andersson and Göran Berg and has published in prestigious journals such as The Journal of Immunology, Cancer and The Journal of Urology.

In The Last Decade

Leif Håkansson

40 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leif Håkansson Sweden 20 553 519 263 196 112 42 1.1k
Anja Dankof Germany 15 348 0.6× 267 0.5× 480 1.8× 232 1.2× 160 1.4× 26 1.3k
J Zeromski Poland 19 537 1.0× 255 0.5× 265 1.0× 71 0.4× 105 0.9× 98 1.2k
Martin Bolli Switzerland 18 629 1.1× 515 1.0× 335 1.3× 408 2.1× 145 1.3× 60 1.3k
Hans‐Jürgen Gruss Germany 16 528 1.0× 547 1.1× 159 0.6× 160 0.8× 256 2.3× 21 1.4k
Ermanno Nardon Italy 15 432 0.8× 183 0.4× 253 1.0× 146 0.7× 121 1.1× 22 1.1k
Janet Siebert United States 17 623 1.1× 564 1.1× 275 1.0× 110 0.6× 143 1.3× 41 1.2k
H Kodo Japan 16 600 1.1× 419 0.8× 166 0.6× 126 0.6× 97 0.9× 50 1.4k
Toshikazu Shimbo Japan 14 224 0.4× 506 1.0× 292 1.1× 260 1.3× 109 1.0× 27 1.3k
Nancy Craighead United States 16 1.4k 2.6× 549 1.1× 283 1.1× 100 0.5× 38 0.3× 22 1.9k
Achilleas Floudas Ireland 19 679 1.2× 227 0.4× 244 0.9× 139 0.7× 68 0.6× 32 1.3k

Countries citing papers authored by Leif Håkansson

Since Specialization
Citations

This map shows the geographic impact of Leif Håkansson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leif Håkansson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leif Håkansson more than expected).

Fields of papers citing papers by Leif Håkansson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leif Håkansson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leif Håkansson. The network helps show where Leif Håkansson may publish in the future.

Co-authorship network of co-authors of Leif Håkansson

This figure shows the co-authorship network connecting the top 25 collaborators of Leif Håkansson. A scholar is included among the top collaborators of Leif Håkansson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leif Håkansson. Leif Håkansson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Copier, John, Angus Dalgleish, Cedrik M. Britten, et al.. (2009). Improving the efficacy of cancer immunotherapy. European Journal of Cancer. 45(8). 1424–1431. 35 indexed citations
2.
Clinchy, Birgitta, et al.. (2007). Pre-operative interleukin-6 production by mononuclear blood cells predicts survival after radical surgery for colorectal carcinoma (49.31). The Journal of Immunology. 178(1_Supplement). S89–S89.
3.
4.
5.
Clinchy, Birgitta, et al.. (2006). Production of IL-1Ra by human mononuclear blood cells in vitro: Influence of serum factors. Cytokine. 34(5-6). 320–330. 5 indexed citations
6.
Roberg, Karin, et al.. (2005). Effects of cytokines on matrix metalloproteinase expression in oral squamous cell carcinoma in vitro. Acta Oto-Laryngologica. 125(7). 765–773. 23 indexed citations
7.
Bergkvist, Leif, et al.. (2004). CD28 expression in sentinel node biopsies from breast cancer patients in comparison with CD3-ζ chain expression. Journal of Translational Medicine. 2(1). 45–45. 24 indexed citations
8.
Bernsen, Monique R., et al.. (2003). On the biological relevance of MHC class II and B7 expression by tumour cells in melanoma metastases. British Journal of Cancer. 88(3). 424–431. 41 indexed citations
9.
Lacombe, Denis, P. Fumoleau, H. Zwierzina, et al.. (2002). The EORTC and drug development. European Journal of Cancer. 38. 19–23. 16 indexed citations
10.
Håkansson, Annika, Leif Håkansson, Bertil Gustafsson, et al.. (2002). Biochemotherapy of metastatic malignant melanoma. On down-regulation of CD28. Cancer Immunology Immunotherapy. 51(9). 499–504. 15 indexed citations
11.
Håkansson, Annika, et al.. (2001). Biochemotherapy of metastatic malignant melanoma. Predictive value of tumour-infiltrating lymphocytes. British Journal of Cancer. 85(12). 1871–1877. 24 indexed citations
12.
Håkansson, Annika, et al.. (1999). Expression of ICAM-1 During IFN-alpha-Based Treatment of Metastatic Malignant Melanoma: Relation to Tumor-Infiltrating Mononuclear Cells and Regressive Tumor Changes. Journal of Interferon & Cytokine Research. 19(2). 171–177. 7 indexed citations
13.
Håkansson, Annika, Bertil Gustafsson, Lennart Krysander, & Leif Håkansson. (1998). Effect of IFN-α on Tumor-Infiltrating Mononuclear Cells and Regressive Changes in Metastatic Malignant Melanoma. Journal of Interferon & Cytokine Research. 18(1). 33–39. 35 indexed citations
14.
Håkansson, Leif, Gunnar Adell, B Boeryd, Florence Sjögren, & Rune Sjödahl. (1997). Infiltration of mononuclear inflammatory cells into primary colorectal carcinomas: an immunohistological analysis. British Journal of Cancer. 75(3). 374–380. 37 indexed citations
15.
Harsten, Andreas, Lars Gillberg, Leif Håkansson, & M J Olsson. (1997). Intrathecal sufentanil compared with epidural bupivacaine analgesia in labour. European Journal of Anaesthesiology. 14(6). 642–645. 9 indexed citations
16.
Håkansson, Annika, Bertil Gustafsson, Lennart Krysander, & Leif Håkansson. (1996). Tumour-infiltrating lymphocytes in metastatic malignant melanoma and response to interferon alpha treatment. British Journal of Cancer. 74(5). 670–676. 72 indexed citations
17.
Sander, Birgitta, et al.. (1996). Localization of IL-1, IL-2, IL-4, IL-8 and TNF in Superficial Bladder Tumors Treated with Intravesical Bacillus Calmette-Guerin. The Journal of Urology. 536–541. 2 indexed citations
18.
Thyberg, Mikael, Per Ertzgaard, Leif Håkansson, Anders Spångberg, & Göran Granérus. (1995). Obstructive effect of a closed 12F urethral catheter during the emptying phase of cystometry in patients with a spinal reflex bladder. Spinal Cord. 33(1). 40–45. 1 indexed citations
19.
Starkhammar, Hans, et al.. (1987). Intra-Arterial Mitomycin C Treatment of Unresectable Liver Tumours: Preliminary results on the effect of degradable starch microspheres. Acta Oncologica. 26(4). 295–300. 13 indexed citations
20.
Starkhammar, Hans, et al.. (1987). Effect of microspheres in intra-arterial chemotherapy. A study of arterio-venous shunting and passage of a labelled marker. Medical Oncology and Tumor Pharmacotherapy. 4(2). 87–96. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anja Dankof Breakdown of academic impact, for papers by J Zeromski Breakdown of academic impact, for papers by Martin Bolli Breakdown of academic impact, for papers by Hans‐Jürgen Gruss Breakdown of academic impact, for papers by Ermanno Nardon Breakdown of academic impact, for papers by Janet Siebert Breakdown of academic impact, for papers by H Kodo Breakdown of academic impact, for papers by Toshikazu Shimbo Breakdown of academic impact, for papers by Nancy Craighead Breakdown of academic impact, for papers by Achilleas Floudas
Rankless by CCL
2026